SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Lexaria Enters Pharmaceutical Agreement for DehydraTECH

Lexaria says it entered an agreement with an unnamed pharmaceutical company to investigate its DehydraTECH drug-delivery platform.

LEXX

Story updates

02:00:52 PM UTC
SquawkNews
Lexaria entered an agreement with an unnamed pharmaceutical company to evaluate DehydraTECH with one or more proprietary molecules. If evaluation is successful, the parties may consider a licensing agreement; terms were not disclosed.Material DetailsContext by AI AnalystThis is an early-stage partn…

Related stories